CaffeineToxicity TestsCentral Nervous System StimulantsTheobromineCoffeeToxicity Tests, AcuteDose-Response Relationship, DrugRyanodineCytochrome P-450 CYP1A2CalciumProcaineLethal Dose 50Drug Administration SchedulePhosphodiesterase InhibitorsAntineoplastic Combined Chemotherapy ProtocolsToxicity Tests, ChronicTime FactorsAntineoplastic AgentsDrug InteractionsAdministration, OralSarcoplasmic ReticulumRyanodine Receptor Calcium Release ChannelTreatment OutcomeReceptor, Adenosine A2ABeveragesCell SurvivalInfusions, IntravenousCisplatinEphedrineAdenosine A2 Receptor AntagonistsReceptor, Adenosine A1Muscle ContractionPaulliniaMalignant HyperthermiaRats, Sprague-DawleyDrinking BehaviorNo-Observed-Adverse-Effect LevelFluorouracilPurinergic P1 Receptor AntagonistsDoxorubicinTeratogensMaximum Tolerated DoseNeoplasmsAdenosine A1 Receptor AntagonistsCells, CulturedTetracaineDrug SynergismReceptors, Adenosine A2Double-Blind MethodCombined Modality TherapyAntineoplastic Agents, PhytogenicLiverApneaToxicologyDrug-Induced Liver InjuryRats, Wistar